{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:48:06Z","timestamp":1792723686291,"version":"4.5.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100013128","name":"Multiple System Atrophy Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013128","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000320","name":"Alzheimer&apos;s Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000320","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002283","name":"Alzheimer&apos;s Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002283","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Much research into the aetiology of Alzheimer\u2019s disease (AD) has focused on neuronal cell types, while studies on the contribution of glial cells, particularly oligodendrocytes (OLGs), are only starting to emerge. Altered brain DNA methylation, an epigenetic modification that provides the interplay between genetics and environmental cues to tightly regulate gene expression, is well documented in AD. Yet, cell-type-specific investigations remain limited. Here, we examine the role of DNA methylation and OLGs in AD, and how such changes may impact gene expression. We performed weighted-gene correlation network analysis (WGCNA) on multiple brain omics AD datasets across species: human DNA methylation data from 4 brain regions, human brain single-nuclei RNA sequencing data and mouse brain RNA sequencing data. We compared AD-associated network modules enriched for OLG genes across AD brain regions, as well as with other neurodegenerative disease DNA methylation datasets. We identified a DNA methylation signature associated with AD, enriched for OLGs, and preserved across brain regions representing early and late AD pathology stages. Genes within this signature showed altered expression in AD OLGs, confirming cell-type specificity and relevance to AD. This OLG signature was also preserved in transgenic mice with early A\u03b2 pathology and in other neurodegenerative diseases without A\u03b2 pathology. We reveal a consistent pattern of OLG dysfunction spanning early to late stages of AD, across DNA methylation and gene expression. Our findings highlight OLG-associated DNA methylation changes as important in AD pathogenesis, and possibly in other neurodegenerative diseases, opening new avenues for therapeutic development.<\/jats:p>","DOI":"10.1038\/s41380-026-03686-1","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T07:56:47Z","timestamp":1781769407000},"page":"5966-5978","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Early oligodendrocyte dysfunction signature in Alzheimer\u2019s disease: Insights from DNA methylomics and transcriptomics"],"prefix":"10.1038","volume":"31","author":[{"given":"Katherine","family":"Fodder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah M. G.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umran","family":"Yaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignazio S.","family":"Piras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megha","family":"Murthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammaryn","family":"Lashley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5052-5775","authenticated-orcid":false,"given":"Rohan","family":"de Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dervis A.","family":"Salih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9090-7690","authenticated-orcid":false,"given":"Concei\u00e7\u00e3o","family":"Bettencourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"key":"3686_CR1","doi-asserted-by":"crossref","unstructured":"Alzheimer\u2019s Association. 2021 Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 2021;17: 327\u2013406.","DOI":"10.1002\/alz.12328"},{"key":"3686_CR2","doi-asserted-by":"publisher","first-page":"345","DOI":"10.5114\/aoms.2018.76863","volume":"16","author":"E Papu\u0107","year":"2020","unstructured":"Papu\u0107 E, Rejdak K. The role of myelin damage in Alzheimer\u2019s disease pathology. Arch Med Sci: AMS. 2020;16:345\u2013345.","journal-title":"Arch Med Sci: AMS"},{"key":"3686_CR3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40478-018-0515-3","volume":"6","author":"SE Nasrabady","year":"2018","unstructured":"Nasrabady SE, Rizvi B, Goldman JE, Brickman AM. White matter changes in Alzheimer\u2019s disease: a focus on myelin and oligodendrocytes. Acta Neuropathol Commun. 2018;6:22\u201322.","journal-title":"Acta Neuropathol Commun"},{"key":"3686_CR4","doi-asserted-by":"publisher","unstructured":"Fodder K, de Silva R, Warner TT, Bettencourt C The contribution of DNA methylation to the (dys)function of oligodendroglia in neurodegeneration. Acta Neuropathol Commun. 2023;11106. https:\/\/doi.org\/10.1186\/s40478-023-01607-9.","DOI":"10.1186\/s40478-023-01607-9"},{"key":"3686_CR5","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1038\/s42003-022-04248-1","volume":"5","author":"I Molina-Gonzalez","year":"2022","unstructured":"Molina-Gonzalez I, Miron VE, Antel JP. Chronic oligodendrocyte injury in central nervous system pathologies. Commun Biol. 2022;5:1274.","journal-title":"Commun Biol"},{"key":"3686_CR6","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.neuropharm.2016.06.034","volume":"110","author":"JK Huang","year":"2016","unstructured":"Huang JK, K\u00e1rad\u00f3ttir RT. Oligodendrocytes in health and disease. Neuropharmacology. 2016;110:537\u20138.","journal-title":"Neuropharmacology"},{"key":"3686_CR7","doi-asserted-by":"publisher","unstructured":"Bradl M, Lassmann H Oligodendrocytes: biology and pathology. https:\/\/doi.org\/10.1007\/s00401-009-0601-5.","DOI":"10.1007\/s00401-009-0601-5"},{"key":"3686_CR8","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s004010050508","volume":"92","author":"H Braak","year":"1996","unstructured":"Braak H, Braak E. Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis. Acta Neuropathol. 1996;92:197\u2013201.","journal-title":"Acta Neuropathol"},{"key":"3686_CR9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1001\/jamaneurol.2016.3232","volume":"74","author":"DC Dean 3rd","year":"2017","unstructured":"Dean DC 3rd, Hurley SA, Kecskemeti SR, O\u2019Grady JP, Canda C, Davenport-Sis NJ, et al. Association of amyloid pathology with myelin alteration in preclinical Alzheimer disease. JAMA Neurol. 2017;74:41\u201349.","journal-title":"JAMA Neurol"},{"key":"3686_CR10","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/glia.22432","volume":"61","author":"G Behrendt","year":"2013","unstructured":"Behrendt G, Baer K, Buffo A, Curtis MA, Faull RL, Rees MI, et al. Dynamic changes in myelin aberrations and oligodendrocyte generation in chronic amyloidosis in mice and men. Glia. 2013;61:273\u201386.","journal-title":"Glia"},{"key":"3686_CR11","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/j.1365-2990.2007.00828.x","volume":"33","author":"JE Simpson","year":"2007","unstructured":"Simpson JE, Fernando MS, Clark L, Ince PG, Matthews F, Forster G, et al. White matter lesions in an unselected cohort of the elderly: astrocytic, microglial and oligodendrocyte precursor cell responses. Neuropathol Appl Neurobiol. 2007;33:410\u20139.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"3686_CR12","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/j.1750-3639.2012.00595.x","volume":"22","author":"E Gagyi","year":"2012","unstructured":"Gagyi E, Kormos B, Castellanos KJ, Valyi-Nagy K, Korneff D, LoPresti P, et al. Decreased oligodendrocyte nuclear diameter in Alzheimer\u2019s disease and Lewy body dementia. Brain Pathol. 2012;22:803\u201310.","journal-title":"Brain Pathol"},{"key":"3686_CR13","doi-asserted-by":"publisher","first-page":"e16616","DOI":"10.1371\/journal.pone.0016616","volume":"6","author":"X Hu","year":"2011","unstructured":"Hu X, Pickering E, Liu YC, Hall S, Fournier H, Katz E, et al. Meta-analysis for genome-wide association study identifies multiple variants at the BIN1 locus associated with late-onset Alzheimer\u2019s disease. PLoS ONE. 2011;6:e16616.","journal-title":"PLoS ONE"},{"key":"3686_CR14","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","volume":"51","author":"BW Kunkle","year":"2019","unstructured":"Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, et al. Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates A\u03b2, tau, immunity and lipid processing. Nat Genet. 2019;51:414\u201330.","journal-title":"Nat Genet"},{"key":"3686_CR15","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/ng.2802","volume":"45","author":"JC Lambert","year":"2013","unstructured":"Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease. Nat Genet. 2013;45:1452\u20138.","journal-title":"Nat Genet"},{"key":"3686_CR16","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/S13024-016-0124-1","volume":"11","author":"P De Rossi","year":"2016","unstructured":"De Rossi P, Buggia-Pr\u00e9vot V, Clayton BLL, Vasquez JB, Van Sanford C, Andrew RJ, et al. Predominant expression of Alzheimer\u2019s disease-associated BIN1 in mature oligodendrocytes and localization to white matter tracts. Mol Neurodegener. 2016;11:59 https:\/\/doi.org\/10.1186\/S13024-016-0124-1.","journal-title":"Mol Neurodegener"},{"key":"3686_CR17","doi-asserted-by":"publisher","first-page":"e3002727","DOI":"10.1371\/journal.pbio.3002727","volume":"22","author":"RM Rajani","year":"2024","unstructured":"Rajani RM, Ellingford R, Hellmuth M, Harris SS, Taso OS, Graykowski D, et al. Selective suppression of oligodendrocyte-derived amyloid beta rescues neuronal dysfunction in Alzheimer\u2019s disease. PLoS Biol. 2024;22:e3002727.","journal-title":"PLoS Biol"},{"key":"3686_CR18","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.jalz.2017.09.012","volume":"14","author":"M Allen","year":"2018","unstructured":"Allen M, Wang X, Burgess JD, Watzlawik J, Serie DJ, Younkin CS, et al. Conserved brain myelination networks are altered in Alzheimer\u2019s and other neurodegenerative diseases. Alzheimer\u2019s & Dementia. 2018;14:352\u201366.","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"3686_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.902261","volume":"10","author":"JC Nowacki","year":"2022","unstructured":"Nowacki JC, Fields AM, Fu MM. Emerging cellular themes in leukodystrophies. Front Cell Dev Biol. 2022;10:902261.","journal-title":"Front Cell Dev Biol"},{"key":"3686_CR20","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1086\/342259","volume":"71","author":"J Paloneva","year":"2002","unstructured":"Paloneva J, Manninen T, Christman G, Hovanes K, Mandelin J, Adolfsson R, et al. Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype. Am J Hum Genet. 2002;71:656\u201362.","journal-title":"Am J Hum Genet"},{"key":"3686_CR21","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa1211851","volume":"368","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, et al. TREM2 variants in Alzheimer\u2019s disease. N Engl J Med. 2013;368:117\u201327.","journal-title":"N Engl J Med"},{"key":"3686_CR22","doi-asserted-by":"publisher","first-page":"179.e17","DOI":"10.1016\/j.neurobiolaging.2018.01.015","volume":"66","author":"C Sassi","year":"2018","unstructured":"Sassi C, Nalls MA, Ridge PG, Gibbs JR, Lupton MK, Troakes C, et al. Mendelian adult-onset leukodystrophy genes in Alzheimer\u2019s disease: critical influence of CSF1R and NOTCH3. Neurobiol Aging. 2018;66:179.e17\u2013179.e29.","journal-title":"Neurobiol Aging"},{"key":"3686_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-013-0415-7","volume":"13","author":"AM Brickman","year":"2013","unstructured":"Brickman AM. Contemplating Alzheimer\u2019s disease and the contribution of white matter hyperintensities. Curr Neurol Neurosci Rep. 2013;13:415.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"3686_CR24","doi-asserted-by":"publisher","first-page":"P885","DOI":"10.1016\/j.jalz.2015.08.093","volume":"11","author":"DC Dean III","year":"2015","unstructured":"Dean DC III, Sojkova J, Hurley S, O\u2019Grady P, Canda C-M, Davenport NJ, et al. P4\u2010264: Amyloid pathology is associated with extensive myelin alteration in preclinical Alzheimer\u2019s disease: New insights into disease process with novel brain imaging. Alzheimers Dement. 2015;11:P885\u2013P885.","journal-title":"Alzheimers Dement"},{"key":"3686_CR25","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41586-023-06120-6","volume":"618","author":"C Depp","year":"2023","unstructured":"Depp C, Sun T, Sasmita AO, Spieth L, Berghoff SA, Nazarenko T, et al. Myelin dysfunction drives amyloid-\u03b2 deposition in models of Alzheimer\u2019s disease. Nature. 2023;618:349\u201357.","journal-title":"Nature"},{"key":"3686_CR26","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1093\/brain\/awae339","volume":"148","author":"AC Graham","year":"2025","unstructured":"Graham AC, Bellou E, Harwood JC, Yaman U, Celikag M, Magusali N, et al. Human longevity and Alzheimer\u2019s disease variants act via microglia and oligodendrocyte gene networks. Brain. 2025;148:969\u201384.","journal-title":"Brain"},{"key":"3686_CR27","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s00401-019-01966-5","volume":"137","author":"SA Semick","year":"2019","unstructured":"Semick SA, Bharadwaj RA, Collado-Torres L, Tao R, Shin JH, Deep-Soboslay A, et al. Integrated DNA methylation and gene expression profiling across multiple brain regions implicate novel genes in Alzheimer\u2019s disease. Acta Neuropathol. 2019;137:557\u201369.","journal-title":"Acta Neuropathol"},{"key":"3686_CR28","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1111\/nan.12757","volume":"47","author":"M Murthy","year":"2021","unstructured":"Murthy M, Cheng YY, Holton JL, Bettencourt C. Neurodegenerative movement disorders: An epigenetics perspective and promise for the future. Neuropathol Appl Neurobiol. 2021;47:897\u2013909.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"3686_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-23243-4","volume":"12","author":"RG Smith","year":"2021","unstructured":"Smith RG, Pishva E, Shireby G, Smith AR, Roubroeks JAY, Hannon E, et al. A meta-analysis of epigenome-wide association studies in Alzheimer\u2019s disease highlights novel differentially methylated loci across cortex. Nat Commun. 2021;12:1\u201313.","journal-title":"Nat Commun"},{"key":"3686_CR30","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1038\/nn.3786","volume":"17","author":"PL De Jager","year":"2014","unstructured":"De Jager PL, Srivastava G, Lunnon K, Burgess J, Schalkwyk LC, Yu L, et al. Alzheimer\u2019s disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci. Nat Neurosci. 2014;17:1156\u201363.","journal-title":"Nat Neurosci"},{"key":"3686_CR31","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1038\/nn.3782","volume":"17","author":"K Lunnon","year":"2014","unstructured":"Lunnon K, Smith R, Hannon E, De Jager PL, Srivastava G, Volta M, et al. Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer\u2019s disease. Nat Neurosci. 2014;17:1164\u201370.","journal-title":"Nat Neurosci"},{"key":"3686_CR32","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.jalz.2018.01.017","volume":"14","author":"RG Smith","year":"2018","unstructured":"Smith RG, Hannon E, De Jager PL, Chibnik L, Lott SJ, Condliffe D, et al. Elevated DNA methylation across a 48\u2010kb region spanning the HOXA gene cluster is associated with Alzheimer\u2019s disease neuropathology. Alzheimers Dement. 2018;14:1580\u20138.","journal-title":"Alzheimers Dement"},{"key":"3686_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/S13073-015-0258-8","volume":"8","author":"CT Watson","year":"2016","unstructured":"Watson CT, Roussos P, Garg P, Ho DJ, Azam N, Katsel PL, et al. Genome-wide DNA methylation profiling in the superior temporal gyrus reveals epigenetic signatures associated with Alzheimer\u2019s disease. Genome Med. 2016;8:5 https:\/\/doi.org\/10.1186\/S13073-015-0258-8.","journal-title":"Genome Med"},{"key":"3686_CR34","doi-asserted-by":"crossref","unstructured":"Shireby G, Dempster EL, Policicchio S, Smith RG, Pishva E, Chioza B, et al. DNA methylation signatures of Alzheimer's disease neuropathology in the cortex are primarily driven by variation in non-neuronal cell-types. Nat Commun. 2022;13:5620.","DOI":"10.1038\/s41467-022-33394-7"},{"key":"3686_CR35","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/nan.12650","volume":"46","author":"AR Smith","year":"2020","unstructured":"Smith AR, Wheildon G, Lunnon K. Invited Review - A 5-year update on epigenome-wide association studies of DNA modifications in Alzheimer\u2019s disease: progress, practicalities and promise. Neuropathol Appl Neurobiol. 2020;46:641\u201353.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"3686_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-19791-w","volume":"11","author":"L Zhang","year":"2020","unstructured":"Zhang L, Silva TC, Young JI, Gomez L, Schmidt MA, Hamilton-Nelson KL, et al. Epigenome-wide meta-analysis of DNA methylation differences in prefrontal cortex implicates the immune processes in Alzheimer\u2019s disease. Nat Commun. 2020;11:1\u201313.","journal-title":"Nat Commun"},{"key":"3686_CR37","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/S13072-018-0211-3","volume":"11","author":"G Gasparoni","year":"2018","unstructured":"Gasparoni G, Bultmann S, Lutsik P, Kraus TFJ, Sordon S, Vlcek J, et al. DNA methylation analysis on purified neurons and glia dissects age and Alzheimer\u2019s disease-specific changes in the human cortex. Epigenetics Chromatin. 2018;11:41 https:\/\/doi.org\/10.1186\/S13072-018-0211-3.","journal-title":"Epigenetics Chromatin"},{"key":"3686_CR38","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s00401-019-02074-0","volume":"139","author":"C Bettencourt","year":"2020","unstructured":"Bettencourt C, Foti SC, Miki Y, Botia J, Chatterjee A, Warner TT, et al. White matter DNA methylation profiling reveals deregulation of HIP1, LMAN2, MOBP, and other loci in multiple system atrophy. Acta Neuropathol. 2020;139:135.","journal-title":"Acta Neuropathol"},{"key":"3686_CR39","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btu049","author":"MJ Aryee","year":"2014","unstructured":"Aryee MJ, Jaffe AE, Corrada-Bravo H, Ladd-Acosta C, Feinberg AP, Hansen KD, et al. Minfi: A flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics. 2014. https:\/\/doi.org\/10.1093\/bioinformatics\/btu049.","journal-title":"Bioinformatics"},{"key":"3686_CR40","doi-asserted-by":"crossref","unstructured":"Pidsley R, Y Wong CC, Volta M, Lunnon K, Mill J, Schalkwyk LC. A data-driven approach to preprocessing Illumina 450K methylation array data. BMC Genomics. 2013;14:293.","DOI":"10.1186\/1471-2164-14-293"},{"key":"3686_CR41","doi-asserted-by":"publisher","unstructured":"Tian Y, Morris TJ, Webster AP, Yang Z, Beck S, Feber A, et al. ChAMP: Updated methylation analysis pipeline for Illumina BeadChips. Bioinformatics. 2017. https:\/\/doi.org\/10.1093\/bioinformatics\/btx513","DOI":"10.1093\/bioinformatics\/btx513"},{"key":"3686_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-11-587","volume":"11","author":"P Du","year":"2010","unstructured":"Du P, Zhang X, Huang CC, Jafari N, Kibbe WA, Hou L, et al. Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis. BMC Bioinformatics. 2010;11:587 https:\/\/doi.org\/10.1186\/1471-2105-11-587.","journal-title":"BMC Bioinformatics"},{"key":"3686_CR43","doi-asserted-by":"crossref","unstructured":"Fodder K, Murthy M, Rizzu P, Toomey CE, Hasan R, Humphrey J, et al. Brain DNA methylomic analysis of frontotemporal lobar degeneration reveals OTUD4 in shared dysregulated signatures across pathological subtypes. Acta Neuropathologica 2023. 2023;1:1\u201319.","DOI":"10.1007\/s00401-023-02583-z"},{"key":"3686_CR44","doi-asserted-by":"publisher","unstructured":"Mathys H, Davila-Velderrain J, Peng Z, Gao F, Mohammadi S, Young JZ, et al. Single-cell transcriptomic analysis of Alzheimer\u2019s disease. Nature. https:\/\/doi.org\/10.1038\/s41586-019-1195-2.","DOI":"10.1038\/s41586-019-1195-2"},{"key":"3686_CR45","doi-asserted-by":"crossref","unstructured":"Hao Y, Hao S, Andersen-Nissen E, Mauck WM 3rd, Zheng S, Butler A, et al. Integrated analysis of multimodal single-cell data. Cell. 2021;184:3573\u201387.e29.","DOI":"10.1016\/j.cell.2021.04.048"},{"key":"3686_CR46","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcz022","volume":"1","author":"DA Salih","year":"2019","unstructured":"Salih DA, Bayram S, Guelfi S, Reynolds RH, Shoai M, Ryten M, et al. Genetic variability in response to amyloid beta deposition influences Alzheimer\u2019s disease risk. Brain Commun. 2019;1:fcz022.","journal-title":"Brain Commun"},{"key":"3686_CR47","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.celrep.2014.12.041","volume":"10","author":"M Matarin","year":"2015","unstructured":"Matarin M, Salih DA, Yasvoina M, Cummings DM, Guelfi S, Liu W, et al. A genome-wide gene-expression analysis and database in transgenic mice during development of amyloid or tau pathology. Cell Rep. 2015;10:633\u201344.","journal-title":"Cell Rep"},{"key":"3686_CR48","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nmeth.4197","volume":"14","author":"R Patro","year":"2017","unstructured":"Patro R, Duggal G, Love MI, Irizarry RA, Kingsford C. Salmon provides fast and bias-aware quantification of transcript expression. Nat Methods. 2017;14:417\u20139.","journal-title":"Nat Methods"},{"key":"3686_CR49","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.12688\/f1000research.7563.1","volume":"4","author":"C Soneson","year":"2015","unstructured":"Soneson C, Love MI, Robinson MD. Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences. F1000Res. 2015;4:1521.","journal-title":"F1000Res"},{"key":"3686_CR50","doi-asserted-by":"publisher","unstructured":"Langfelder P, Horvath S WGCNA: An R package for weighted correlation network analysis. BMC Bioinformatics. 2008. https:\/\/doi.org\/10.1186\/1471-2105-9-559.","DOI":"10.1186\/1471-2105-9-559"},{"key":"3686_CR51","doi-asserted-by":"publisher","unstructured":"Bot\u00eda JA, Vandrovcova J, Forabosco P, Guelfi S, D\u2019Sa K, Hardy J, et al. An additional k-means clustering step improves the biological features of WGCNA gene co-expression networks. BMC Syst Biol. 2017. https:\/\/doi.org\/10.1186\/s12918-017-0420-6.","DOI":"10.1186\/s12918-017-0420-6"},{"key":"3686_CR52","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1126\/science.aaa1934","volume":"347","author":"A Zeisel","year":"2015","unstructured":"Zeisel A, Mu\u00f1oz-Manchado AB, Codeluppi S, L\u00f6nnerberg P, Manno GL, Jur\u00e9us A, et al. Cell types in the mouse cortex and hippocampus revealed by single-cell RNA-seq. Science. 2015;347:1138\u201342.","journal-title":"Science"},{"key":"3686_CR53","first-page":"16","volume":"0","author":"NG Skene","year":"2016","unstructured":"Skene NG, Grant SGN. Identification of vulnerable cell types in major brain disorders using single cell transcriptomes and expression weighted cell type enrichment. Front Neurosci. 2016;0:16\u201316.","journal-title":"Front Neurosci"},{"key":"3686_CR54","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.euroneuro.2021.12.003","volume":"56","author":"IS Piras","year":"2022","unstructured":"Piras IS, Huentelman MJ, Pinna F, Paribello P, Solmi M, Murru A, et al. A review and meta-analysis of gene expression profiles in suicide. Eur Neuropsychopharmacol. 2022;56:39\u201349. https:\/\/doi.org\/10.1016\/j.euroneuro.2021.12.003.","journal-title":"Eur Neuropsychopharmacol"},{"key":"3686_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.crmeth.2023.100498","volume":"3","author":"S Morabito","year":"2023","unstructured":"Morabito S, Reese F, Rahimzadeh N, Miyoshi E, Swarup V. hdWGCNA identifies co-expression networks in high-dimensional transcriptomics data. Cell Rep Methods. 2023;3:100498.","journal-title":"Cell Rep Methods"},{"key":"3686_CR56","doi-asserted-by":"publisher","first-page":"e1001057","DOI":"10.1371\/journal.pcbi.1001057","volume":"7","author":"P Langfelder","year":"2011","unstructured":"Langfelder P, Luo R, Oldham MC, Horvath S. Is my network module preserved and reproducible? PLoS Comput Biol. 2011;7:e1001057.","journal-title":"PLoS Comput Biol"},{"key":"3686_CR57","doi-asserted-by":"publisher","first-page":"e1004219","DOI":"10.1371\/journal.pcbi.1004219","volume":"11","author":"CA de Leeuw","year":"2015","unstructured":"de Leeuw CA, Mooij JM, Heskes T, Posthuma D. MAGMA: generalized gene-set analysis of GWAS data. PLoS Comput Biol. 2015;11:e1004219.","journal-title":"PLoS Comput Biol"},{"key":"3686_CR58","doi-asserted-by":"publisher","first-page":"529","DOI":"10.3389\/fimmu.2017.00529","volume":"8","author":"P Peschl","year":"2017","unstructured":"Peschl P, Bradl M, H\u00f6ftberger R, Berger T, Reindl M. Myelin oligodendrocyte glycoprotein: Deciphering a target in inflammatory demyelinating diseases. Front Immunol. 2017;8:529.","journal-title":"Front Immunol"},{"key":"3686_CR59","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00401-023-02596-8","volume":"146","author":"A Tiane","year":"2023","unstructured":"Tiane A, Schepers M, Reijnders RA, van Veggel L, Chenine S, Rombaut B, et al. From methylation to myelination: epigenomic and transcriptomic profiling of chronic inactive demyelinated multiple sclerosis lesions. Acta Neuropathol. 2023;146:283\u201399.","journal-title":"Acta Neuropathol"},{"key":"3686_CR60","doi-asserted-by":"publisher","first-page":"e148005","DOI":"10.1172\/JCI148005","volume":"131","author":"K Segawa","year":"2021","unstructured":"Segawa K, Kikuchi A, Noji T, Sugiura Y, Hiraga K, Suzuki C, et al. A sublethal ATP11A mutation associated with neurological deterioration causes aberrant phosphatidylcholine flipping in plasma membranes. J Clin Invest. 2021;131:e148005 https:\/\/doi.org\/10.1172\/JCI148005.","journal-title":"J Clin Invest"},{"key":"3686_CR61","doi-asserted-by":"publisher","first-page":"12528","DOI":"10.1523\/JNEUROSCI.1069-12.2012","volume":"32","author":"M Koenning","year":"2012","unstructured":"Koenning M, Jackson S, Hay CM, Faux C, Kilpatrick TJ, Willingham M, et al. Myelin gene regulatory factor is required for maintenance of myelin and mature oligodendrocyte identity in the adult CNS. J Neurosci. 2012;32:12528\u201342.","journal-title":"J Neurosci"},{"key":"3686_CR62","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13024-017-0219-3","volume":"12","author":"AT McKenzie","year":"2017","unstructured":"McKenzie AT, Moyon S, Wang M, Katsyv I, Song W-M, Zhou X, et al. Multiscale network modeling of oligodendrocytes reveals molecular components of myelin dysregulation in Alzheimer\u2019s disease. Mol Neurodegener. 2017;12:82.","journal-title":"Mol Neurodegener"},{"key":"3686_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13962-0","volume":"11","author":"T Yan","year":"2020","unstructured":"Yan T, Liang J, Gao J, Wang L, Fujioka H, Alzheimer Disease Neuroimaging Initiative. et al. FAM222A encodes a protein which accumulates in plaques in Alzheimer\u2019s disease. Nat Commun. 2020;11:411.","journal-title":"Nat Commun"},{"key":"3686_CR64","doi-asserted-by":"publisher","first-page":"S249","DOI":"10.3233\/JAD-221241","volume":"99","author":"J Liang","year":"2024","unstructured":"Liang J, LaFleur B, Hussainy S, Perry G. Gene co-expression analysis of multiple brain tissues reveals correlation of FAM222A expression with multiple Alzheimer\u2019s disease-related genes. J Alzheimers Dis. 2024;99:S249\u2013S263.","journal-title":"J Alzheimers Dis"},{"key":"3686_CR65","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s00401-024-02764-4","volume":"148","author":"M Murthy","year":"2024","unstructured":"Murthy M, Fodder K, Miki Y, Rambarack N, De Pablo Fernandez E, Pihlstr\u00f8m L, et al. DNA methylation patterns in the frontal lobe white matter of multiple system atrophy, Parkinson\u2019s disease, and progressive supranuclear palsy: a cross-comparative investigation. Acta Neuropathol. 2024;148:4.","journal-title":"Acta Neuropathol"},{"key":"3686_CR66","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/j.1750-3639.2007.00054.x","volume":"17","author":"DW Dickson","year":"2007","unstructured":"Dickson DW, Rademakers R, Hutton ML. Progressive supranuclear palsy: pathology and genetics. Brain Pathol. 2007;17:74\u201382.","journal-title":"Brain Pathol"},{"key":"3686_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-022-01879-0","volume":"12","author":"J Fessel","year":"2022","unstructured":"Fessel J. Abnormal oligodendrocyte function in schizophrenia explains the long latent interval in some patients. Transl Psychiatry. 2022;12:120.","journal-title":"Transl Psychiatry"},{"key":"3686_CR68","doi-asserted-by":"crossref","unstructured":"Bright A, Akay LA, Blanchard J, Tsai L-H. Emerging connections between myelin and Alzheimer's disease. Nat Cell Biol. 2025;27:1049\u201351.","DOI":"10.1038\/s41556-025-01701-1"},{"key":"3686_CR69","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s12264-021-00678-9","volume":"37","author":"H Huang","year":"2021","unstructured":"Huang H, Zhou F, Zhou S, Qiu M. MYRF: A mysterious membrane-bound transcription factor involved in myelin development and human diseases. Neurosci Bull. 2021;37:881\u20134.","journal-title":"Neurosci Bull"},{"key":"3686_CR70","doi-asserted-by":"publisher","first-page":"e1003907","DOI":"10.1371\/journal.pgen.1003907","volume":"9","author":"J Hornig","year":"2013","unstructured":"Hornig J, Fr\u00f6b F, Vogl MR, Hermans-Borgmeyer I, Tamm ER, Wegner M. The transcription factors Sox10 and Myrf define an essential regulatory network module in differentiating oligodendrocytes. PLoS Genet. 2013;9:e1003907.","journal-title":"PLoS Genet"},{"key":"3686_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-026-68864-9","volume":"17","author":"SR Oatman","year":"2026","unstructured":"Oatman SR, Reddy JS, Atashgaran A, Wang X, Min Y, Quicksall Z, et al. Integrative epigenomic landscape of Alzheimer\u2019s Disease brains reveals oligodendrocyte molecular perturbations associated with tau. Nat Commun. 2026;17:2116.","journal-title":"Nat Commun"},{"key":"3686_CR72","first-page":"1","volume":"2022","author":"JW Blanchard","year":"2022","unstructured":"Blanchard JW, Akay LA, Davila-Velderrain J, von Maydell D, Mathys H, Davidson SM, et al. APOE4 impairs myelination via cholesterol dysregulation in oligodendrocytes. Nature. 2022;2022:1\u201311.","journal-title":"Nature"},{"key":"3686_CR73","doi-asserted-by":"publisher","first-page":"977","DOI":"10.3233\/JAD-210497","volume":"83","author":"F Cioffi","year":"2021","unstructured":"Cioffi F, Adam RHI, Bansal R, Broersen K. A review of oxidative stress products and related genes in early Alzheimer\u2019s disease. J Alzheimers Dis. 2021;83:977\u20131001.","journal-title":"J Alzheimers Dis"},{"key":"3686_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25353-5","volume":"12","author":"M Zhang","year":"2021","unstructured":"Zhang M, Wang J, Zhang K, Lu G, Liu Y, Ren K, et al. Ten-eleven translocation 1 mediated-DNA hydroxymethylation is required for myelination and remyelination in the mouse brain. Nat Commun. 2021;12:5091.","journal-title":"Nat Commun"},{"key":"3686_CR75","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.neurobiolaging.2020.05.016","volume":"94","author":"I Vanzulli","year":"2020","unstructured":"Vanzulli I, Papanikolaou M, De-La-Rocha IC, Pieropan F, Rivera AD, Gomez-Nicola D, et al. Disruption of oligodendrocyte progenitor cells is an early sign of pathology in the triple transgenic mouse model of Alzheimer\u2019s disease. Neurobiol Aging. 2020;94:130\u20139.","journal-title":"Neurobiol Aging"},{"key":"3686_CR76","doi-asserted-by":"publisher","first-page":"9793","DOI":"10.7150\/thno.118737","volume":"15","author":"M Sarhan","year":"2025","unstructured":"Sarhan M, Wohlfeld C, Perry-Mills A, Meyers J, Fadel J, Murphy EA, et al. The pathophysiology of mixed Alzheimer\u2019s disease and vascular dementia. Theranostics. 2025;15:9793\u2013818.","journal-title":"Theranostics"},{"key":"3686_CR77","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcac109","volume":"4","author":"V Planche","year":"2022","unstructured":"Planche V, Manjon JV, Mansencal B, Lanuza E, Tourdias T, Catheline G, et al. Structural progression of Alzheimer\u2019s disease over decades: the MRI staging scheme. Brain Commun. 2022;4:fcac109.","journal-title":"Brain Commun"},{"key":"3686_CR78","doi-asserted-by":"crossref","unstructured":"Menden K, Francescatto M, Nyima T, Blauwendraat C, Dhingra A, Castillo-Lizardo M, et al. A multi-omics dataset for the analysis of frontotemporal dementia genetic subtypes. Sci Data. 2023;10:849.","DOI":"10.1038\/s41597-023-02598-x"},{"key":"3686_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05325-y","volume":"9","author":"A Weber","year":"2018","unstructured":"Weber A, Schwarz SC, Tost J, Tr\u00fcmbach D, Winter P, Busato F, et al. Epigenome-wide DNA methylation profiling in Progressive Supranuclear Palsy reveals major changes at DLX1. Nat Commun. 2018;9:2929 https:\/\/doi.org\/10.1038\/s41467-018-05325-y.","journal-title":"Nat Commun"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03686-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03686-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03686-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T07:38:46Z","timestamp":1789112326000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03686-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":79,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["3686"],"URL":"https:\/\/doi.org\/10.1038\/s41380-026-03686-1","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]},"assertion":[{"value":"10 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This study is a secondary analysis of publicly available datasets. Ethical approval and informed consent were obtained by the original study investigators, as described in the corresponding publications. No new human participants were recruited or studied directly by the authors and this study does not include identifiable data from human research participants. No additional ethical approval or informed consent were, therefore, required for the present analysis. The study that generated the primary postmortem human DNA methylation brain tissue dataset was approved by the NIMH\/NIH Institutional Review Board (protocol 90-M-0142) with informed consent obtained from the legal next of kin. ROSMAP datasets were generated from studies approved by the Rush University Medical Center Institutional Review Board, with informed consent obtained from all participants. The mouse gene expression dataset was generated in accordance with the UK Animals (Scientific Procedures) Act 1986, with local ethical approval and in accordance with the GlaxoSmithKline statement on the use of animals. All methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}